Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-17

FDA Approved: MIDAZOLAM — Supplemental Application (Steriscience Specialties Private Limited)

View source ↗

Summary

FDA approved a supplemental application for Midazolam hydrochloride (Midazolam) by Steriscience Specialties Private Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midazolam (Midazolam)

Snippet

SUPPL AP for MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE)